β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma

Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma

(2013) Dong-Yan Shen et al.   CANCER SCIENCE

Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo

(2012) Yong-Wei Wang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

β-Escin sodium inhibits inducible nitric oxide synthase expression via downregulation of the JAK/STAT pathway in A549 cells

(2011) Deng Bo Ji et al.   MOLECULAR CARCINOGENESIS

Apoptosis of Human Cholangiocarcinoma Cell Lines induced by β-Escin through Mitochondrial Caspase-dependent Pathway

(2011) Dong-Yan Shen et al.   PHYTOTHERAPY RESEARCH

Tamoxifen reverses the multi-drug-resistance of an established human cholangiocarcinoma cell line in combined chemotherapeutics

(2010) Zhi-Hua Liu et al.   MOLECULAR BIOLOGY REPORTS

Establishment and identification of the human multi-drug-resistant cholangiocarcinoma cell line QBC939/ADM

(2010) Zhi-Hua Liu et al.   MOLECULAR BIOLOGY REPORTS

β-Escin, a natural triterpenoid saponin from Chinese horse chestnut seeds, depresses HL-60 human leukaemia cell proliferation and induces apoptosis RETRACTED ARTICLE

(2008) Yang P. Niu et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY